Articles published by Merck & Co., Inc.
Merck Announces First-Quarter 2023 Financial Results
April 27, 2023
From Merck & Co., Inc.
Via Business Wire
Tickers
MRK
Merck Provides Update on Phase 3 Trials KEYNOTE-641 and KEYNOTE-789
February 28, 2023
From Merck & Co., Inc.
Via Business Wire
Tickers
MRK
Merck and Ridgeback Provide Update on EU Marketing Authorization Application for LAGEVRIO™ (Molnupiravir)
February 24, 2023
From Merck & Co., Inc.
Via Business Wire
Tickers
MRK
Merck Announces Fourth-Quarter and Full-Year 2022 Financial Results
February 02, 2023
From Merck & Co., Inc.
Via Business Wire
Tickers
MRK
Merck Animal Health Receives U.S. FDA Approval of Expanded Indication for BRAVECTO (fluralaner) Chews for Dogs
January 26, 2023
From Merck & Co., Inc.
Via Business Wire
Tickers
MRK
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.